US 12215133
GIP and GLP-1 dual receptor agonist, pharmaceutical composition, and use
granted A61KA61K38/00A61K38/26
Quick answer
US patent 12215133 (GIP and GLP-1 dual receptor agonist, pharmaceutical composition, and use) held by BrightGene Bio-Medical Technology Co., Ltd. expires Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BrightGene Bio-Medical Technology Co., Ltd.
- Grant date
- Tue Feb 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K38/00, A61K38/26, A61P, A61P3/10